123 related articles for article (PubMed ID: 32594599)
1. Therapeutic implications of immunohistochemical expression pattern of the cancer stem cell marker (nestin) in basal and squamous cell carcinomas.
Rabea AR; Elshahid AR; Elhakim MS; Hashish YH; Jafferany M; Elsaie ML
Dermatol Ther; 2020 Nov; 33(6):e13921. PubMed ID: 32594599
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
Sabet MN; Rakhshan A; Erfani E; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
[TBL] [Abstract][Full Text] [Related]
3. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
Kanoh M; Amoh Y; Sato Y; Katsuoka K
Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
5. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
6. Role of suprabasin, a new biomarker in squamous cell carcinoma and basal cell carcinoma.
Ucer O; Kocaman N
Tissue Cell; 2022 Oct; 78():101875. PubMed ID: 35930991
[TBL] [Abstract][Full Text] [Related]
7. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
8. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
9. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior.
Weninger W; Rendl M; Pammer J; Grin W; Petzelbauer P; Tschachler E
J Cutan Pathol; 1997 Jul; 24(6):364-9. PubMed ID: 9243364
[TBL] [Abstract][Full Text] [Related]
10. Expression of stem cell markers nestin and cytokeratin 15 and 19 in cutaneous malignancies.
Abbas O; Bhawan J
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):311-6. PubMed ID: 20629844
[TBL] [Abstract][Full Text] [Related]
11. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Erfani E; Roudi R; Rakhshan A; Sabet MN; Shariftabrizi A; Madjd Z
Int J Biol Markers; 2016 Feb; 31(1):e53-61. PubMed ID: 26391478
[TBL] [Abstract][Full Text] [Related]
12. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
13. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
Suiqing C; Min Z; Lirong C
J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
[TBL] [Abstract][Full Text] [Related]
15. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
16. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
[TBL] [Abstract][Full Text] [Related]
17. The expression of c-erbB-1 and c-erbB-2 oncogenes in basal cell carcinoma and squamous cell carcinoma of skin.
Liu B; Zhang H; Li S; Chen W; Li R
Chin Med Sci J; 1996 Jun; 11(2):106-9. PubMed ID: 9387420
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors.
Franz R; Ritter N; Hein R; Biedermann T; Al-Sisi M; Eyerich K; Garzorz-Stark N; Andres C
Am J Dermatopathol; 2017 Oct; 39(10):742-746. PubMed ID: 28857981
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study of CD56 and Smooth Muscle Actin Expression in Basal and Squamous Cell Carcinomas.
Yirmibes S; Balaban Adim S
Am J Dermatopathol; 2023 Dec; 45(12):816-819. PubMed ID: 37982465
[TBL] [Abstract][Full Text] [Related]
20. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]